Gilead enters $2B immuno-oncology deal with Arcus Biosciences
Under the 10-year deal, Gilead will have the right to option product candidates from Arcus' pipeline, with the companies sharing responsibility for development and commercialization.
Under the 10-year deal, Gilead will have the right to option product candidates from Arcus' pipeline, with the companies sharing responsibility for development and commercialization.
New research by the Cancer Research Institute puts the number of industry-wide combination trials at 1,105.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.